Join us as we speak to Dr. Anand Patel and Dr. Satyajit Kosuri from The University of Chicago Medicine about the latest treatment advances for myelodysplastic syndromes (MDS). In honor of MDS Awareness Day on October 25th, the doctors discuss how MDS develops, why genetic mutations matter when choosing a treatment course, and how stem cell transplantation, targeted treatments and cellular therapies bring hope to MDS patients and their families.

Mentioned on this episode: 

• Myelodysplastic syndromes
• Acute Myeloid Leukemia
• Transplant Support and Graft-Versus-Host-Disease (GVHD) episode
• Patient-Doctor Perspectives: Hereditary Myelodysplastic Syndromes (MDS)
• Transplant Optimization Program (TOP)
• MyeloMATCH initiative
• CAR T-cell Therapy
• Stem Cell Transplant
• Cellular Therapies
• Graft-Vs-Host Disease
• Be The Match – Bone Marrow Donor Registry

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Young Adult Resources
• Survivorship Workbook
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

The post Instilling Hope Through Progress: Myelodysplastic Syndromes (MDS) first appeared on The Bloodline with Blood Cancer United Podcast.

Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies.

Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK Inhibitors, CAR T-cell therapy and other treatments have come on the market and have increased the possibilities for patients to live a long life with CLL.

Mentioned on this episode: 

• Chronic Lymphocyctic Leukemia (CLL)
• How CAR T Cell Therapy Gives Hope to Cancer Patients Podcast Episode
• CURE Magazine Article on CAR T and Young CLL Patients
• American Journal of Managed Care – CAR T cells persist
• Minimal/Measurable Residual Disease (MRD) Fact Sheet
• CAR T-cell Therapy
• CAR T-Cell Therapy Webinar
• How CAR T-Cell Therapy Works In Augmented Reality
• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• LLS COVID-19 Resources
• Clinical Trial Support Center
• The Bloodline Subscriber Lounge

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by BeiGene USA, Inc.; Bristol Myers Squibb; Genentech, Inc. & Biogen; Loxo Oncology at Lilly and Pharmacyclics, An AbbVie Company & Janssen Biotech, and Thomas D. Oxley Fund for CLL Patient Education and Support.

The post Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with Blood Cancer United Podcast.

Please join us as we speak to Dr. Shernan Holtan and guest co-host from LLS, Christina Neilsen. In this episode, Dr. Holtan discusses stem cell transplants; how they work, the different types of transplants, and the side effects, including graft-vs-host disease (GVHD).

Dr. Holtan shares exciting new research on reducing GVHD and provides blood cancer patients with hope as transplantations continue to improve and bring about potential cures.

Mentioned on this episode: 

• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• Graft-verses-Host Disease Fact Sheet
• CAR T-cell Therapy
• Clinical Trial Support Center
• Hope Lodge
• Posttransplant Cyclophosphamide
• Be The Match

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

The post Let’s Talk About Stem Cell Transplantation: Benefits and Side Effects first appeared on The Bloodline with Blood Cancer United Podcast.

Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine.  In this episode, Dr. Pollyea discusses the group of diseases that make up Myelodysplastic Syndromes (MDS) and how their variability leads to different treatments and prognoses, from active monitoring to chemotherapy and/or stem cell transplantation.  He shares his excitement about new treatment advances and is looking forward to an era of innovative targeted treatments for MDS.

Mentioned on this episode: 

• Myelodysplastic Syndromes (MDS)
• Myelodysplastic Syndromes (MDS) Booklets
• Acute Myeloid Leukemia (AML)
• Stem Cell Transplant
• IPSS-R Scoring System
• IPSS-M Scoring System
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by Taiho Oncology.

The post Myelodysplastic Syndromes (MDS): A Group of Diseases first appeared on The Bloodline with Blood Cancer United Podcast.

Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). In this episode, Charles tells us about his treatment for AML, participation in clinical trials, and shares about his struggle to find a bone marrow donor as an Asian Pacific Islander. Charles then turned his struggle into legislation to make it easier to join a bone marrow donor registry to save lives. Dr. Mannis, of Stanford Medicine, shares about the latest advances in AML research, from clinical trials in Chimeric Antigen Receptor (CAR) therapy to medications that reduce graft-vs-host disease (GVHD). With research advancing quickly in the field of AML treatment, patients and caregivers are given reasons to have hope after the uncertainty of a diagnosis.

Mentioned on this episode: 

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes (MDS)
• Minimal/Measurable Residual Disease
• CAR T-cell Therapy
• Stem Cell Transplant
• Graft-Vs-Host-Disease (GVHD)
• Charlie’s Law
• Be The Match – Bone Marrow Donor Registry
• LLS Advocacy & Public Policy
• Innovative Therapies in Acute Leukemias podcast episode

Additional LLS Support Resources: 

• Information Specialists
• Free telephone/web patient programs 
• Clinical Trial Support Center
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Myeloma Link
• Patti Robinson Kaufmann First Connection Program 
• Young Adult Resources
• Survivorship Workbook

Support for this episode provided by Astellas and Genentech, Inc & Biogen.

The post Patient-Doctor Perspectives: Hope in the Uncertainty of AML first appeared on The Bloodline with Blood Cancer United Podcast.

Join us as we speak to Dr. Hongtao Liu and Dr. Adam DuVall from University of Chicago Medicine, about current and emerging cellular therapies for acute leukemias. These innovative therapies include CAR T-cell therapy, modified Natural Killer (NK) cells and stem cell transplantations. In this episode, we discuss how these groundbreaking therapies have changed the landscape of treatment for acute leukemias. The doctors share what they are excited about in the future, citing how clinical trials are advancing therapies and how cancer centers can better serve the unique needs of adolescent and young adults (AYAs) with acute leukemias by utilizing a holistic and comprehensive approach.

Mentioned on this episode: 

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• CAR T-cell Therapy
• Stem Cell Transplant
• Cellular Therapies
• Minimal/Measurable Residual Disease (MRD)
• Graft-Vs-Host Disease
• Adolescent and Young Adult (AYA) Oncology Program at University of Chicago
• CALMM Clinic at University of Chicago
• Young Adult Resources
• Survivorship Workbook
• Between Two Kingdoms

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

The post Innovative Therapies for Acute Leukemias first appeared on The Bloodline with Blood Cancer United Podcast.

Join us as we speak to Dr. Peter Riedell and Dr. Benjamin Derman from University of Chicago Medicine, about the latest research coming out of the annual meeting of the American Society of Hematology (ASH). In this episode, we discuss new treatments on the horizon for lymphoma and myeloma. The doctors share how innovative therapies such as CAR T-cell therapy and new combinations of medicines are showing significant promise, providing further hope to patients.

Mentioned on this episode: 

• Lymphoma
• Myeloma
• Amyloidosis
• MGUS (Monoclonal Gammopathy of Undetermined Significance)
• Smoldering myeloma (Myeloma staging)
• Minimal/Measurable Residual Disease (MRD)
• Bispecific Antibody Therapy
• ASH Annual Meeting Highlights
• Anxiety and Hope: Living with CLL podcast episode
• Dara-KRd
• CAR T-cell Therapy
• Stem Cell Transplant
• Graft-Vs-Host Disease

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Young Adult Resources
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

The post Emerging Research in Lymphoma and Myeloma first appeared on The Bloodline with Blood Cancer United Podcast.

Join us as we speak to Dr. Brady Stein, a clinical hematologist and researcher at the Northwestern University Feinberg School of Medicine in Chicago, IL. In this episode, Dr. Stein discusses the rare blood cancer, myelofibrosis (MF), which is a type of myeloproliferative neoplasms (MPNs). Hear about the unique characteristics of MF, how it develops, and the current and emerging treatments that give MF patients hope.

Mentioned on this episode: 

• Myelofibrosis
• Myeloproliferative Neoplasms
• ASH (American Society of Hematology)
• Pushing for a Diagnosis: A Polycythemia Vera (PV) Story
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations 
• LLS Advocacy
• LLS Myeloma Link

Support for this episode provided by AbbVie.

The post Under the MPN Umbrella: Exploring Myelofibrosis first appeared on The Bloodline with Blood Cancer United Podcast.

Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. In this episode, Dr. Wang delves into the rare blood cancer, blastic plasmacytoid dendritic cell neoplasm (BPDCN). Usually identified by characteristic deep purple lesions, oncologists continue to raise awareness of this rare diagnosis, as swift referral and treatment usually leads to better outcomes. After being universally identified as BPDCN by World Health Organization (WHO) in 2018, clinical trials and CAR T-cell therapies have brought new hope to BPDCN patients.

Mentioned on this episode: 

• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
• Why Roswell Park for Leukemia & Blood Cancers 
• Stem Cell Transplantation
• CAR T-cell Therapy
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations 
• LLS Advocacy
• LLS Myeloma Link

Support for this episode provided by ImmunoGen.

The post Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) first appeared on The Bloodline with Blood Cancer United Podcast.

Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. To celebrate the 100th episode of The Bloodline with LLS, we will be speaking with Mel Mann, a chronic myeloid leukemia (CML) survivor and Dr. Brian Druker, a physician researcher at Oregon Health Sciences University (OHSU). 

Mel shares how Dr. Druker’s research saved his life with the drug, Gleevec®, and we get to hear his inspirational message of how one person can make a difference. Dr. Druker discusses this revolutionary therapy, how it transformed the lives of CML patients like Mel, and how targeted treatments are continuing to transform how we treat cancer. 

Mentioned on this episode:

• Chronic Myeloid Leukemia
• The rise of precision medicine for patients with CML
• TKI Therapy
• Be The Match – Bone Marrow Donor Registry
• LLS Translational Research
• LLS Specialized Centers of Research Program
• Beat AML Master Clinical Trial
• Oral Parity Laws
• LLS Advocacy
• Clinical Trial Support Center
• LLS Myeloma Link

Additional LLS Support Resources:

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations 

Support for this episode provided by Pfizer.

The post Patient-Doctor Perspectives: Groundbreaking Research in CML first appeared on The Bloodline with Blood Cancer United Podcast.